TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/2/24 13:13 | 11/28/24 | VIAV | Viavi Solutions Inc. | DE | Tech | Semicn | Semiconductors & Related Devi | Daskal Ilan | AZ | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 166 | 82 | D | |||||||||||||||
9/6/23 13:00 | 9/1/23 | BIOBI | Bio-Rad Laboratories, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Daskal Ilan | CA | O | EVP,CFO | M.dm | 0 | 0.00 | 0 | 2 | 213 | 2 | D | ||||||||||||||
4/11/23 14:39 | 4/8/23 | BIOBI | Bio-Rad Laboratories, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Daskal Ilan | CA | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 1 | 88 | 1 | D | ||||||||||||||
9/7/22 14:04 | 9/2/22 | BIOBI | Bio-Rad Laboratories, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Daskal Ilan | CA | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 1 | 131 | 1 | D | ||||||||||||||
9/6/22 13:22 | 9/1/22 | BIOBI | Bio-Rad Laboratories, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Daskal Ilan | CA | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 0 | 201 | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |